BioSpace News Archive

Alderya Therapeutics (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection, USP), an investigational drug candidate, for the treatment of primary vitreoretinal lymphoma (PVRL).

Quest Diagnostics Incorporated (NYSE: DGX) announced that it will report second quarter 2023 financial results on Wednesday, July 26, 2023, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

Bayer, one of the country’s leading life-sciences companies, announced its new Senior Bayer Representative and President of Bayer U.S. This press release features multimedia.

Theranica announced the results of a study recently published in Headache demonstrating the safety of the Nerivio® migraine bioband, a novel Remote Electrical Neuromodulation (REN) wearable, as a drug-free treatment for pregnant women with migraine.

Integral Molecular is proud to announce that the Commonwealth of Pennsylvania has awarded the company $1M of funding through the Redevelopment Assistance Capital Program that will be used to support the further expansion of the company’s new headquarters and buildout of its Pandemic Research Center in Philadelphia.

Laboratory digital transformation pioneer Scitara has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) partner network with its Digital Lab Exchange DLX™ cloud platform. The two organizations are now also embarking on a collaboration to develop next-generation products to drive digital transformation in the lab.

MaaT Pharma, a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to improving survival outcomes for patients with cancer, announced new appointments to its Board and Executive team.

The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar along with diet and exercise in children 10 years and older with type 2 diabetes, Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced.

Eloxx Pharmaceuticals, Inc., a leader in ribosomal RNA-targeted genetic therapies for rare diseases, announced that it will host an Investor and Analyst call and webcast on Tuesday, June 27, 2023 at 11:30 am ET.

RLS, Inc., the third-largest nuclear medicine pharmacy network in the US, and SOFIE Biosciences, a national US manufacturer and developer of PET radiopharmaceuticals, entered into a strategic partnership for RLS to distribute SOFIE nuclear medicine doses for patients.